4DX 11.1% 60.0¢ 4dmedical limited

Research, page-468

  1. 266 Posts.
    lightbulb Created with Sketch. 118

    Medical Equipment & Devices - Overnight Price: $1.30

    Bell Potter rates ((4DX)) as Upgrade to Buy from Hold (1) -

    4Medical has announced iMed as its Australian clinical pilot program partner for the XV Lung Ventilation Analysis Software. The trial will commence Phase 2, expanding out of Victoria.

    Bell Potter notes the decision to expand the trial to further sites suggests clinicians are gaining benefits from the technology and the system is likely integrating well with the normal radiology practice workflows.

    The broker highlights an announcement of a commercial supply arrangement for the above mentioned software will be a catalyst for the stock.

    The rating is upgraded to Buy from Hold and the target price increases to $2.00 from $1.80.

    The report was published on September 8, 2021.

    Target price is $2.00 Current Price is $1.30 Difference: $0.7
    If 4DX meets the Bell Potter target it will return approximately 54% (excluding dividends, fees and charges).
    The company's fiscal year ends in June.




 
watchlist Created with Sketch. Add 4DX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.